CRL · Earnings call · 2026Q2T · Full report

NHP Regulatory Investigation Resolution

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 47 · Surprise 60

Management said control of the nonhuman-primate supply chain is providing clients greater assurance that studies can begin when needed and without timing delays. Charles River manages when animals are brought in, quarantined, and placed on studies, which management characterized as a competitive differentiator and a factor deepening preferred-client relationships. The company reported an uptick in capture rate over the last few months, although management said it was too early to call that a sustained trend. Management also noted that the full impact of the Cambodia acquisition and divestitures is expected to provide a positive margin tailwind in 2027, without giving formal 2027 margin guidance.